Insider · CIK 0001819427
Kelly Deck
Files at INBX (Inhibrx Biosciences, Inc.). First filing -, latest -.
Kelly Deck files SEC Form 4 as CFO at INBX (Inhibrx Biosciences, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Kelly Deck has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 1, 2025 | INBX Inhibrx Biosciences, Inc. | AGrant or award Stock Option (right to buy)derivative | +15,000 | $0.00 | $0 | 15,000 | Apr 2, 2025 |
Questions about Kelly Deck
Answered from the filings on this page, as of the latest one.
Is Kelly Deck buying or selling?
Kelly Deck has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Kelly Deck's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kelly Deck has 0.
Where does Kelly Deck file Form 4?
Kelly Deck has filed Form 4 at INBX (Inhibrx Biosciences, Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.